<DOC>
	<DOCNO>NCT00896701</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood bone marrow patient cancer laboratory may help doctor predict response patient previously treat interleukin-2 . PURPOSE : This laboratory study look relationship natural killer cell ' ability kill leukemia cell outcome patient acute myeloid leukemia previously treat interleukin-2 .</brief_summary>
	<brief_title>Relationship Between Natural Killer Cells ' Ability Kill Leukemia Cells Outcome Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2</brief_title>
	<detailed_description>OBJECTIVES : - Correlate vitro lysis autologous pre-treatment leukemic blast cell interleukin-2 ( IL-2 ) -expanded natural killer ( NK ) cell relapse-free survival patient acute myeloid leukemia ( AML ) treat interleukin-2 ( IL-2 ) . - Correlate expression inhibitory ( MHC class I ) activate ligand AML blast cell relapse-free survival patient . - Correlate expression activate inhibitory NK receptor IL-2-expanded cell relapse-free survival patient . - Compare susceptibility autologous NK cell lysis leukemic blast obtain diagnosis blast obtain relapse patient . OUTLINE : This multicenter study . Patients stratify accord age ( &lt; 60 v â‰¥ 60 year ) cytogenetic risk category ( favorable v average vs poor ) . Previously bank tissue sample leukemic blast cell bone marrow natural killer ( NK ) cell peripheral blood mononuclear cell thaw analyze . Surface expression leukemic blast co-stimulatory molecule , know activate NKG2D ligand , MHC class I inhibitory ligand NK cell receptor quantify monoclonal antibody analysis flow cytometry . Mean cell fluorescence intensity ( MCFI ) ligand correlate relapse-free survival patient .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Interleukin-2</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis acute myeloid leukemia Prior treatment interleukin2 require Previously enrol CLB9621 , CLB9720 , CALGB19808 Previously consent companion Leukemia Tissue Bank Protocol CALGB9665 store follow specimen : Bone marrow blast cell procure diagnosis relapse ( available ) Peripheral blood mononuclear cell obtain remission PATIENT CHARACTERISTICS : Age 15</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>adult acute myeloid leukemia remission</keyword>
	<keyword>recurrent adult acute myeloid leukemia</keyword>
	<keyword>adult acute myeloid leukemia 11q23 ( MLL ) abnormality</keyword>
	<keyword>adult acute myeloid leukemia inv ( 16 ) ( p13 ; q22 )</keyword>
	<keyword>adult acute myeloid leukemia ( 15 ; 17 ) ( q22 ; q12 )</keyword>
	<keyword>adult acute myeloid leukemia ( 16 ; 16 ) ( p13 ; q22 )</keyword>
	<keyword>adult acute myeloid leukemia ( 8 ; 21 ) ( q22 ; q22 )</keyword>
</DOC>